Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study
NCT ID: NCT03909230
Last Updated: 2021-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2019-04-02
2019-05-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endometriosis Impact on Oocyte Quality
NCT03241329
Isolation and Characterization of the Extracellular Vesicles Secreted by the Human Endometrium
NCT02797834
Measuring Endometrial Blood Flow Using Laser Doppler: Acceptability & Reproducibility
NCT04906551
Non Invasive Diagnostic of Endometrial Receptivity
NCT01588223
Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood
NCT06245512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is generally believed that the viscosity change post ovulation is influenced by the luteal phase endocrine milieu, and it is possible that the viscosity of the endometrial fluid has an impact on implantation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Day 2 post ovulation
Ultrasound of the endometrium, Endometrial fluid sample, Blood sample
No interventions assigned to this group
Day 4 post ovulation
Ultrasound of the endometrium, Endometrial fluid sample, Blood sample
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women eligible and qualified for egg donation at IVIRMA Bilbao
* Proven fertile (having given birth to at least one spontaneously conceived normal child)
* Signed written consent including sharing of anonymized data
Exclusion Criteria
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anecova SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVIRMA Bilbao
Leioa, Vizcaya, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCV-VIS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.